These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 12215269)
1. High in vivo production of a model monoclonal antibody on adenoviral gene transfer. Noël D; Pelegrin M; Kramer S; Jacquet C; Skander N; Piechaczyk M Hum Gene Ther; 2002 Aug; 13(12):1483-93. PubMed ID: 12215269 [TBL] [Abstract][Full Text] [Related]
2. Skin as a potential organ for ectopic monoclonal antibody production. Noël D; Dazard JE; Pelegrin M; Jacquet C; Piechaczyk M J Invest Dermatol; 2002 Feb; 118(2):288-94. PubMed ID: 11841546 [TBL] [Abstract][Full Text] [Related]
3. Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation. Perez N; Bigey P; Scherman D; Danos O; Piechaczyk M; Pelegrin M Genet Vaccines Ther; 2004 Mar; 2(1):2. PubMed ID: 15038826 [TBL] [Abstract][Full Text] [Related]
4. Sustained muscle expression of dystrophin from a high-capacity adenoviral vector with systemic gene transfer of T cell costimulatory blockade. Jiang Z; Schiedner G; van Rooijen N; Liu CC; Kochanek S; Clemens PR Mol Ther; 2004 Oct; 10(4):688-96. PubMed ID: 15451453 [TBL] [Abstract][Full Text] [Related]
5. An antibody delivery system for regulated expression of therapeutic levels of monoclonal antibodies in vivo. Fang J; Yi S; Simmons A; Tu GH; Nguyen M; Harding TC; VanRoey M; Jooss K Mol Ther; 2007 Jun; 15(6):1153-9. PubMed ID: 17375065 [TBL] [Abstract][Full Text] [Related]
6. Sustained systemic delivery of monoclonal antibodies by genetically modified skin fibroblasts. Noël D; Pelegrin M; Brockly F; Lund AH; Piechaczyk M J Invest Dermatol; 2000 Oct; 115(4):740-5. PubMed ID: 10998153 [TBL] [Abstract][Full Text] [Related]
7. Ex vivo gene transfer to mature skeletal muscle by using adenovirus helper cells. Kimura S; Ikezawa M; Cao B; Kanda Y; Pruchnic R; Cummins J; Huard J; Miike T; Suzuki S J Gene Med; 2004 Feb; 6(2):155-65. PubMed ID: 14978769 [TBL] [Abstract][Full Text] [Related]
19. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host. Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802 [TBL] [Abstract][Full Text] [Related]
20. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV. Skaricic D; Traube C; De B; Joh J; Boyer J; Crystal RG; Worgall S Virology; 2008 Aug; 378(1):79-85. PubMed ID: 18556039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]